Masimo has announced a groundbreaking update to its advanced health-tracking wearable, the Masimo W1® Sport. The new feature, Sleep Halo™, offers scientifically based sleep analysis, setting a new standard in sleep tracking technology. Unmatched Sleep Data Tracking and Comprehensive Sleep Insights Sleep Halo™ delivers unparalleled overnight sleep data tracking, recording […]
Tag: MASIMO
ITC Judge Rules Apple Violated Masimo Pulse Oximeter Patent
A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple Watches with light-based pulse oximetry functionality and components, which infringe one of Masimo’s pulse oximeter patents. […]
Former Masimo Engineer Stole Pulse Oximeter Trade Secrets
The United States District Court for the Central District of California has ruled that a former Masimo engineer misappropriated trade secrets related to Masimo’s pulse oximetry technology. The former Masimo engineer, Marcelo Lamego, also served as Chief Technical Officer at Cercacor, a Masimo spinoff that owns certain license rights to […]
Study Finds RMP with Masimo SafetyNet Reduced Hospital Stay for COVID Patients
Masimo has announced the findings of a two-part retrospective study published in Telemedicine and e-Health in which Dr. Hemali Patel and colleagues at the University of Colorado and UC Health (UCH) in Aurora, Colorado evaluated the impact of remote patient monitoring (RPM) of COVID-19 patients using Masimo SafetyNet® on hospital […]
Masimo SET Pulse Oximetry, No Racial Bias Found
Masimo announced the findings of an abstract presented at the Society for Technology in Anesthesia 2022 Annual Meeting, which reviewed retrospective pulse oximetry data and concluded that there was no clinically significant bias based on ethnicity for black and white volunteer subjects monitored with Masimo SET® pulse oximetry and RD […]
Masimo Rad-G Helps Clinicians Identify Pediatric Pneumonia
Masimo has announced the findings of a study published in Clinical Medicine Insights: Pediatrics in which Dr. Harish Kumar and colleagues at IPE Global in New Delhi, India reported on their experience using the Masimo Rad-G® Pulse Oximeter to aid health providers in pneumonia case detection and management in more […]
Masimo Launches Dual SET Pulse Oximetry
Masimo has announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and the addition of […]
New Study Evaluates the Feasibility of Using Masimo EMMA Capnography on Mechanically Ventilated Neonates
Masimo announced the findings of a study published in the European Journal of Pediatrics in which Dr. Masashi Hotta and colleagues at the Osaka Women’s and Children’s Hospital in Japan found that the Masimo EMMA® Portable Capnograph “may be considered an effective monitoring device” for mechanically ventilated preterm infants (neonates).1 Noting the importance […]
Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology
Masimo announced that Founder, Chairman, and CEO Joe Kiani has been appointed by President Joe Biden to the President’s Council of Advisors on Science and Technology (PCAST). The President’s video announcement can be found seen above. Since 1933, with the creation by President Franklin D. Roosevelt of a Science Advisory […]
Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3
Masimo announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).1 To gauge the impact, the researchers […]













